Financial Times
UK · 2 hrs ago
Moderna shares soar over 150% on melanoma vaccine trial success
Drugmaker’s cancer shot developed with Merck delivers positive outcome in late-stage trial
Do you trust Financial Times?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!